IP Library Granted Patent US 12,478,679
Granted Patent B2
US 12,478,679 · App. 17/420,133 · Granted Nov 25, 2025

Pharmaceutical carrier for active substances and a pharmaceutical composition containing said carrier

Inventors: Pawel Biernat (Wroclaw, PL); Jan Meler (Smolec, PL)
Assignee: BIOTTS S A
A61K47/20A61K9/06A61K36/718A61K36/9066A61K47/18A61K47/22A61K47/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,679
App. No.
17/420,133
Granted
Nov 25, 2025
Kind
B2
Abstract

The present invention relates to a pharmaceutical carrier for active substances characterized in that it contains a strongly solvating aprotic solvent from the group of sulfoxides, a carbonic acid amide, and a vegetable oil with a high content of unsaturated fatty acids, and a pharmaceutical composition containing the carrier.

Claims (14)

1 . A pharmaceutical homogeneous carrier for both water-soluble active substances and fat-soluble active substances, characterized in that it contains:

a) a sulfoxide in an amount of 0.01% to 5% by weight,

b) a carbonic acid amide in an amount of 0.01% to 2% by weight, and

c) a vegetable oil selected from the group consisting of Chaulmoogra oil, linseed oil, rapeseed oil, peanut oil, sunflower oil, and hemp oil in an amount of 1% to 5% by weight;

wherein vitamin C dissolves in the carrier at 40° C. and vitamin A dissolves in the carrier at room temperature.

2 . The carrier according to claim 1 , characterized in that the solvating aprotic solvent from the group of sulfoxides is dimethyl sulfoxide.

3 . The carrier according to claim 1 , characterized in that the carbonic acid amide is selected from the group consisting of urea, caffeine and caffeine-containing absorption promoters.

4 . The carrier according to claim 1 , characterized in that it additionally contains a natural emulsifier, selected from the group consisting of white wax, yellow wax, Carnauba wax, and lanolin.

5 . The carrier according to claim 1 , characterized in that it further contains a natural emulsifying substance in an amount of 0.001% to 8% by weight.

6 . A semi-solid pharmaceutical composition characterized in that it contains a carrier as defined in claim 1 , excipients, and at least one active substance, wherein the weight ratio of active substances to the carrier is from 1:10 to 2:1 and the carrier constitutes from 1% to 20% by weight of the composition.

7 . The composition according to claim 6 , characterized in that the weight ratio of the active substances to excipients is from 1:2.5 to 1:494, and it has a semi-solid drug form.

8 . The composition according to claim 6 , characterized in that it contains active substances selected from the group consisting of Coptis Chinesis, Curcuma longa extracts and combinations thereof.

9 . The composition according to claim 6 , characterized in that the excipients are selected from the group consisting of pork lard, duck lard, goose lard, white petrolatum, yellow petrolatum, zinc sulfate, and combinations thereof.

10 . The carrier according to claim 1 , characterized in that the solvating aprotic solvent from the group of sulfoxides is dimethyl sulfoxide and the carbonic acid amide is urea.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BIERNAT, PAWEL; MELER, JAN
To: BIOTTS S A
Reel/Frame 057718/0540 →
Priority Claims (1)
PL 428534 · Jan 10, 2019 · national
Continuity (1)
Related Publication 20220062422A1 · Mar 3, 2022
References Cited (10)
US 5814659A · Elden · 1998 [cited by examiner]
US 20040175415A1 · Chan · 2004 [cited by examiner]
US 20050112153A1 · Wagoner · 2005 [cited by examiner]
JP H1072312 · 1998 [cited by examiner]
PL 286551A1 · 1991 [cited by applicant]
UA 94218U · 2014 [cited by applicant]
WO 2008049401A2 · 2008 [cited by applicant]
Williams and Barry. Penetration enhancers. Advanced Drug Delivery Reviews. 2012, 64, 128-137. [cited by applicant]
Sengupta et al. The component fatty acids of chaulmoogra oil. Journal of the Science of Food and Agriculture, 1973, 24(6), 669-674. [cited by applicant]
International Search Report and Written Opinion, PCT/PL2020/050003, May 7, 2020. [cited by applicant]